Trial Profile
Vascular-Targeted Photodynamic Therapy Using WST11 in Patients With Localized Prostate Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Padeliporfin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Steba Biotech
- 12 Sep 2018 Results (n=313) from PCM201, PCM203 and PCM301 studies published in the Journal of Urology
- 14 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Jul 2012 Planned end date changed from 1 Apr 2012 to 1 Sep 2012 as reported by ClinicalTrials.gov.